{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:15:02Z","timestamp":1790712902385,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":89,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003810","name":"Clinics Hospital of Porto Alegre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006506","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinsp.2025.100643","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:45:15Z","timestamp":1745426715000},"page":"100643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["TeleHCV: A single-visit protocol and minimal passive remote monitoring are sufficient to achieve high SVR with a sofosbuvir-velpatasvir regimen"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8540-3068","authenticated-orcid":false,"given":"Jer\u00f4nimo De Conto","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6991-1174","authenticated-orcid":false,"given":"Fernando Comunello","family":"Schacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2579-2545","authenticated-orcid":false,"given":"Marisa Boff","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8150-8620","authenticated-orcid":false,"given":"Maur\u00edcio Godinho","family":"Kolling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1665-8208","authenticated-orcid":false,"given":"Raquel Boff","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6620-0054","authenticated-orcid":false,"given":"Henrique Cabral","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6823-1022","authenticated-orcid":false,"given":"Paula Martins","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0659-7747","authenticated-orcid":false,"given":"Natan","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8516-8547","authenticated-orcid":false,"given":"Marcelo Rodrigues","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0819-5343","authenticated-orcid":false,"given":"Dimitris Varvaki","family":"Rados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5001-246X","authenticated-orcid":false,"given":"M\u00e1rio Reis","family":"\u00c1lvares-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clinsp.2025.100643_bib0001","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100643_bib0002","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/QCO.0000000000000205","article-title":"The hepatitis C revolution part 1: antiviral treatment options","volume":"28","author":"Thiagarajan","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.clinsp.2025.100643_bib0003","unstructured":"World Health Organization (WHO) (2016). Global report on access to hepatitis C treatment. Focus on overcoming barriers. 2016. Available from https:\/\/www.who.int\/hepatitis\/. (accessed June 19, 2021)."},{"issue":"3","key":"10.1016\/j.clinsp.2025.100643_bib0004","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/liv.14779","article-title":"Progress towards hepatitis C virus elimination in high-income countries: an updated analysis","volume":"41","author":"Gamkrelidze","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.clinsp.2025.100643_bib0005","unstructured":"The CDA Foundation. Hepatitis C. Lafayette, CO: CDA Foundation (2022). Available from http:\/\/polarisobservatory.org\/ and https:\/\/cdafound.org\/polaris-countries-maps. (Accessed october 07, 2024)."},{"issue":"8","key":"10.1016\/j.clinsp.2025.100643_bib0006","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4254\/wjh.v15.i8.973","article-title":"Stages of care for patients with chronic hepatitis C at a hospital in southern Brazil","volume":"15","author":"Vaucher","year":"2023","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100643_bib0007","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(21)00397-6","article-title":"A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial","volume":"7","author":"Solomon","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.clinsp.2025.100643_bib0008","doi-asserted-by":"crossref","first-page":"ciad319","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C Guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating Hepatitis C virus infection","author":"Bhattacharya","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinsp.2025.100643_bib0009","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade (2018). Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de DST, Aids e Hepatites Virais. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Hepatite C e Coinfec\u00e7\u00f5es\/Minist\u00e9rio da Sa\u00fade, Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de DST, Aids e Hepatites Virais. \u2013 Bras\u00edlia: minist\u00e9rio da Sa\u00fade, 2018. Available from http:\/\/www.aids.gov.br\/pt-br\/tags\/publicacoes\/protocolo-clinico-e-diretrizes-terapeuticas (accessed 13 Jun 2021)."},{"key":"10.1016\/j.clinsp.2025.100643_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.877585","article-title":"Interventions to improve uptake of direct-acting antivirals for Hepatitis C virus in priority populations: a systematic review","volume":"10","author":"Ortiz-Paredes","year":"2022","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100643_bib0011","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/a-1777-6112","article-title":"A global systematic review of Hepatitis C elimination efforts through micro-elimination","volume":"42","author":"Lazarus","year":"2022","journal-title":"Semin Liver Dis."},{"issue":"23","key":"10.1016\/j.clinsp.2025.100643_bib0012","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMoa1009370","article-title":"Outcomes of treatment for hepatitis C virus infection by primary care providers","volume":"364","author":"Arora","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100643_bib0013","doi-asserted-by":"crossref","first-page":"874","DOI":"10.5604\/01.3001.0010.5277","article-title":"Direct-acting antiviral therapy outcomes in Canadian chronic Hepatitis C telemedicine patients","volume":"16","author":"Cooper","year":"2017","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100643_bib0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1357633X20963935","article-title":"A telemedicine strategy to reduce waiting lists and time to specialist care: a retrospective cohort study","volume":"29","author":"Pfeil","year":"2023","journal-title":"J Telemed Telecare"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100643_bib0015","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s11605-020-04623-5","article-title":"Telemedicine: patient-provider clinical engagement during the COVID-19 pandemic and beyond","volume":"24","author":"Contreras","year":"2020","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100643_bib0016","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1357633X20916567","article-title":"Telehealth for global emergencies: implications for Coronavirus disease 2019 (COVID-19)","volume":"26","author":"Smith","year":"2020","journal-title":"J Telemed Telecare"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100643_bib0017","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2020.9142","article-title":"Telehealth success spurs a call for greater post-COVID-19 license portability","volume":"324","author":"Slomski","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100643_bib0018","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100643_bib0019","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"European Association for the Study of the Liver. EASL recommendations on treatment of Hepatitis C 2018","volume":"69","author":"Pawlotsky","year":"2018","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100643_bib0020","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1089\/tmj.2015.0210","article-title":"Telehealth in Rio Grande do Sul, Brazil: bridging the gaps","volume":"22","author":"Harzheim","year":"2016","journal-title":"Telemed J E Health"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100643_bib0021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184654","article-title":"Real-life results of sofosbuvir based therapy in chronic hepatitis C -na\u00efve and -experienced patients in Egypt","volume":"12","author":"Nagaty","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100643_bib0022","doi-asserted-by":"crossref","first-page":"959","DOI":"10.5604\/01.3001.0012.7196","article-title":"Efficacy and safety of Ombitasvir\/Paritaprevir\/Ritonavir and Dasabuvir \u00b1 Ribavirin for HCV in Brazilian adults with advanced fibrosis","volume":"17","author":"Pessoa","year":"2018","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100643_bib0023","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.aohep.2018.09.004","article-title":"Sofosbuvir-based antiviral therapy in patients with recurrent HCV infection after liver transplant: a real-life experience","volume":"18","author":"Araujo","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinsp.2025.100643_bib0024","unstructured":"US Department of Health and Human Services (2014), National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS (DAIDS) Table for Grading the Severity of adult and pediatric adverse events, version 2.0. [November 2014]. Available from: https:\/\/rsc.niaid.nih.gov\/sites\/default\/files\/daids-ae-grading-table-v2-nov2014.pdf."},{"issue":"2","key":"10.1016\/j.clinsp.2025.100643_bib0025","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2012 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.clinsp.2025.100643_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"8","key":"10.1016\/j.clinsp.2025.100643_bib0027","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5712\/rbmfc8(29)829","article-title":"Valida\u00e7\u00e3o do instrumento de avalia\u00e7\u00e3o da aten\u00e7\u00e3o prim\u00e1ria \u00e0 sa\u00fade: pCATool-Brasil adultos","volume":"29","author":"Harzheim","year":"2013","journal-title":"Revista Brasileira de Medicina de Fam\u00edlia e Comunidade"},{"issue":"12","key":"10.1016\/j.clinsp.2025.100643_bib0028","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1111\/liv.14227","article-title":"The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals","volume":"39","author":"Bartlett","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.clinsp.2025.100643_bib0029","unstructured":"Swan T. (2015). Overview of new treatments for hepatitis C virus: moving towards a public health agenda. Available from https:\/\/www.who.int\/selection_medicines\/committees\/expert\/20\/reviews\/overview-new-treatments-HEP-C_13-Apr-15.pdf (accessed June 14, 2021)."},{"issue":"5","key":"10.1016\/j.clinsp.2025.100643_bib0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S2468-1253(21)00012-1","article-title":"Decentralised hepatitis C testing and treatment in rural Cambodia: evaluation of a simplified service model integrated in an existing public health system","volume":"6","author":"Zhang","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100643_bib0031","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jhep.2019.10.010","article-title":"Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial","volume":"72","author":"Dore","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100643_bib0032","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.aohep.2019.08.001","article-title":"Members of the Brazilian Real-Life Study about HCV treatment; Members of the Brazilian Real-Life Study about HCV treatment. Direct antiviral therapy for treatment of hepatitis C: a real-world study from Brazil","volume":"18","author":"Lobato","year":"2019","journal-title":"Ann Hepatol"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100643_bib0033","doi-asserted-by":"crossref","first-page":"727","DOI":"10.5604\/01.3001.0010.2717","article-title":"Treatment of chronic HCV infection with the new direct acting antivirals (DAA): first report of a real world experience in southern Brazil","volume":"16","author":"Cheinquer","year":"2017","journal-title":"Ann Hepatol"},{"issue":"12","key":"10.1016\/j.clinsp.2025.100643_bib0034","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1007\/s10620-013-2810-y","article-title":"Clinical outcomes of hepatitis C treated with pegylated interferon and ribavirin via telemedicine consultation in Northern California","volume":"58","author":"Rossaro","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.clinsp.2025.100643_bib0035","doi-asserted-by":"crossref","first-page":"874","DOI":"10.5604\/01.3001.0010.5277","article-title":"Direct-acting antiviral therapy outcomes in Canadian chronic Hepatitis C telemedicine patients","volume":"16","author":"Cooper","year":"2017","journal-title":"Ann Hepatol"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100643_bib0036","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/imj.14072","article-title":"Hepatitis C treatment for difficult to access populations: can telementoring (as distinct from telemedicine) help?","volume":"49","author":"Mohsen","year":"2019","journal-title":"Intern Med J"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100643_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242869","article-title":"Three decades of telemedicine in Brazil: mapping the regulatory framework from 1990 to 2018","volume":"15","author":"Silva","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clinsp.2025.100643_bib0038","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1590\/1413-81232020254.28942019","article-title":"Access and regulation of specialized care in Rio Grande do Sul: the RegulaSUS strategy of Telessa\u00fadeRS-UFRGS. Acesso e regula\u00e7\u00e3o ao cuidado especializado no Rio Grande do Sul: a estrat\u00e9gia RegulaSUS do Telessa\u00fadeRS-UFRGS","volume":"25","author":"Katz","year":"2020","journal-title":"Cien Saude Colet"},{"issue":"11","key":"10.1016\/j.clinsp.2025.100643_bib0039","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1089\/tmj.2015.0210","article-title":"Telehealth in Rio Grande do Sul, Brazil: bridging the gaps","volume":"22","author":"Harzheim","year":"2016","journal-title":"Telemed J E Health"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100643_bib0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12072-019-09927-6","article-title":"Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India","volume":"13","author":"Sood","year":"2019","journal-title":"Hepatol Int"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225000699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225000699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:53:40Z","timestamp":1790711620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593225000699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S1807593225000699"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100643","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TeleHCV: A single-visit protocol and minimal passive remote monitoring are sufficient to achieve high SVR with a sofosbuvir-velpatasvir regimen","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100643"}}